Dashboard › Demo Universe › Evergreen Physician Group

Evergreen Physician Group · EVPG

DEMO DATAUNDERWRITING ASSUMPTIONHOLD

Return analysis — First-Lien Term Loan

HYPOTHETICAL INVESTMENT TERMSUNDERWRITING ASSUMPTION
Face value
$100.0M
Purchase price (assumption)
93.0
Cash investment
$93.5M
Current yield
9.2%
Yield to maturity
11.5%
Base CaseDownsideSevere DownsideExpected
OutcomePerformingDefault (FY2028E)Default (FY2028E)
Face value (legal claim)$100.0M$100.0M$100.0M
Purchase price → cash investment93.0 → $93.5M93.0 → $93.5M93.0 → $93.5M
Cash interest received$25.0M$29.5M$34.0M
Exit price (performing) / recovery proceeds (default)100.0 → $100.0M$102.4M$67.1M
Capital gain / (loss) vs purchase price$7.0M$9.4M($25.9M)
Total cash proceeds$125.0M$131.9M$101.1M
Valuation recovery % · loss given default100% · 0%100% · 0%65% · 35%
Absolute profit$31.6M$38.5M$7.7M
MOIC1.34x1.41x1.08x1.32x
IRR (annual periods)11.0%10.3%2.4%9.5%
IRR (contractual timing, 1x/yr coupons)11.0%10.3%2.4%9.5%
Scenario probability55%30%15%
Required return (hurdle IRR) → statusFAIL 12%FAIL 12%FAIL 12%FAIL
Probability-weighted expected loss
45% P(default) × 12% LGD = 5.2%
Max entry price that still earns the hurdle (base case)
90.8 vs assumed 93.0
Recovery needed for MOIC 1.0x if default
64% of face

Expected column = IRR of the probability-weighted cash flows (9.5%), not the average of scenario IRRs (9.5%); IRR is non-linear. Contractual timing re-times the same coupon dollars to 1 payment(s) per year (settlement on a coupon date, no accrued interest); principal/recovery stay on annual dates. Fees: 0.5% of cost, paid at t=0. Per $100M face. Timing: coupons at period ends; default → recovery cash 1 period after the default period; performing exit at the hold period at the lesser of the scenario exit-price cap and valuation coverage at the exit multiple. Floating coupons include the scenario rate shock. Scenario weights 55% / 30% / 15%.

Sensitivity analysis — where is the risk / return attractive?

Sensitivity 1 — Purchase price vs IRR

Purchase price (% of face)Base CaseDownsideSevere Downside
85.014.7%13.3%5.3%
89.012.8%11.8%3.8%
93.011.0%10.3%2.4%
97.09.4%9.0%1.1%
101.07.8%7.7%-0.1%

Sensitivity 2 — Exit / recovery value (% of face) vs IRR

Proceeds (% of face)Base CaseDownsideSevere Downside
20.0-25.2%-19.4%-17.4%
40.0-12.8%-8.8%-7.2%
60.0-3.4%-1.3%0.2%
80.04.3%4.7%6.1%
100.011.0%9.8%11.1%

Sensitivity 3 — EBITDA margin shift vs IRR (full model re-run)

EBITDA margin shiftBase CaseDownsideSevere Downside
-4.0 pts9.0%1.4%-23.0%
-2.0 pts11.0%8.6%-12.9%
+0.0 pts11.0%10.3%2.4%
+2.0 pts11.0%10.3%8.5%
+4.0 pts11.0%9.4%11.7%

Sensitivity 4 — Revenue growth shift vs IRR (full model re-run)

Revenue growth shiftBase CaseDownsideSevere Downside
-10.0 pts11.0%7.8%-3.9%
-5.0 pts11.0%10.3%-0.7%
+0.0 pts11.0%10.3%2.4%
+5.0 pts11.0%10.3%5.5%
+10.0 pts11.0%10.3%8.6%

Sensitivity 5 — Interest rate (SOFR) shift vs IRR (full model re-run)

SOFR shiftBase CaseDownsideSevere Downside
-1.0 pts10.0%9.4%1.9%
-0.5 pts10.5%9.9%2.1%
+0.0 pts11.0%10.3%2.4%
+1.0 pts12.1%11.2%3.0%
+2.0 pts13.1%12.2%3.5%

Sensitivity 6 — Distressed valuation multiple shift vs target-tranche recovery %

Multiple shift (x EBITDA)Base CaseDownsideSevere Downside
-2.0x100.0%81.9%43.5%
-1.0x100.0%100.0%54.4%
+0.0x100.0%100.0%65.3%
+1.0x100.0%100.0%76.2%
+2.0x100.0%100.0%87.0%

Sensitivity 7 — Recovery / exit value (% of face) vs MOIC

Proceeds (% of face)Base CaseDownsideSevere Downside
20.00.48x0.53x0.58x
40.00.70x0.74x0.79x
60.00.91x0.96x1.01x
80.01.12x1.17x1.22x
100.01.34x1.39x1.43x

Green ≥ hurdle IRR (12%) · amber = positive but below hurdle · red = loss (recovery table: green = full recovery, amber ≥ 60%). Every cell is the same calculation as the Excel Sensitivities tab; margin, growth, rate and multiple tables re-run the entire model (statements → debt → default → recovery → returns).

Return calculator

Face value (legal claim)$100.0M
Cash investment (face × price × (1 + fees))$93.5M
Current yield (coupon ÷ price)9.2%
Cash interest received$25.8M
Exit / recovery proceeds$100.0M
Capital gain / (loss) vs purchase price$7.0M
Total cash proceeds$125.8M
Absolute profit$32.3M
MOIC1.35x
IRR11.3%